Pharmaceutical producer Terapia Ranbaxy, which has recently welcomed back Dragos Damian as CEO after his short stint with producer Actavis, has completed an investment in a 1,600-sqm warehouse in Cluj county.
“I am happy to go back to a company where, together with 700 specialists, I can contribute to the growth and development of an integrated pharmaceutical model,” said Damian, who did not reveal his reasons for leaving Actavis to return to his former employer.
Terapia Ranbaxy will focus on creating an industrial operational hub in Cluj-Napoca to serve the EU market. The warehouse has yet to receive the green light from the National Drug Agency, but the company expects it to be approved by year-end and to start working at full capacity in January next year.
Damian has previously worked as CEO for the local subsidiaries of Zentiva, Actavis and Terapia Ranbaxy.
His term at the helm of Actavis was among his shortest tenures, at just under three months.